Thymosin Alpha-1 Immune Reset

Thymosin alpha-1 (Tα1) is a peptide naturally produced by the thymus gland that plays a key role in T-cell maturation and immune modulation. Its levels decline with age, paralleling the immune dysfunction (immunosenescence) that drives many chronic conditions of later life.\n\nClinically, Tα1 has the longest track record of any therapeutic peptide — it has been used internationally for decades in chronic viral infection management, cancer adjunct therapy, and post-surgical immune support.\n\nAt Spanish Center Dubai, Dr. Razzak uses Tα1 in supervised cycles for patients recovering from chronic infection (including post-viral fatigue and long COVID), those with chronic stress-driven immune dysfunction, and high-performance individuals seeking immune resilience during demanding periods.\n\nDosing is typically 1.6mg subcutaneously twice weekly for 4–8 weeks, followed by reassessment.